do i really have a chance of winning a debate when my side is to continue meds when ca develops?
DESCRIPTION
Pro: An IBD patient on a biologic and/or an immunomodulator, who develops a malignancy: skin cancer solid tumor lymphoma may continue or restart these medications, if needed to treat IBD. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/1.jpg)
1
Pro: An IBD patient on a biologic and/or an immunomodulator, who develops a
malignancy:skin cancersolid tumorlymphoma
may continue or restart these medications, if needed to treat IBD
Miguel Regueiro, MD, FACG, AGAFProfessor of MedicineClinical Head, IBD CenterUniversity of Pittsburgh Medical Ctr
![Page 2: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/2.jpg)
Do I really have a chance of winning a debate when my side is to continue meds when CA develops?
![Page 3: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/3.jpg)
Thank you for slides
• Jim Lewis• Jean Fred Colombel• Corey Siegel (also for photos of Tom!)
3
![Page 4: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/4.jpg)
Important questions in pts who develops cancer on IBD meds:
1. Did the medicine cause the cancer?2. What is the risk of:
- continuing the med in terms of worsening cancer or - discontinuing the med in terms of worsening IBD?
4
![Page 5: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/5.jpg)
Let’s consider three types of cancer:
-Skin Cancer-Lymphoma
- Solid Tumors
5
![Page 6: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/6.jpg)
Case• 50 year old male• 30 year history of small bowel Crohn’s• 1 prior bowel resection• Current meds – 6MP + Adalimumab• 3 BM per day• Colonoscopy – few scattered aphthous
ulcers (i1) in the neo-TI
![Page 7: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/7.jpg)
Case (cont)• 2 years prior diagnosed with Non
Melanoma Skin Cancer (Basal Cell Ca)
• 2 weeks ago newly diagnosed with Squamous Cell Cancer
![Page 8: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/8.jpg)
Is skin cancer caused by or are patients at increased risk from…
-azathioprine/6MP-Methotrexate
-antiTNFs
8
![Page 9: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/9.jpg)
Thiopurines and Skin Cancer
NMSC MELANOMA
Long M. Gastroenterology 2012:143:390-9. Singh H Gastroenterology 2011:141:1612-20Peyrin-Biroulet L. Gastroenterology 2011:141:1621-8Peyrin-Biroulet L. Am J Gastroenterol 2012 doi: 10.1038/ajg.2012.181
![Page 10: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/10.jpg)
Timing of Thiopurines and NMSC (esp. older ages)
Peyrin-Biroulet L. Gastroenterology 2011:141:1621-8
CESAME
![Page 11: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/11.jpg)
Anti-TNF and Skin Cancer (IBD data)
NMSC MELANOMA
Long M. Gastroenterology 2012:143:390-9. Singh H Gastroenterology 2011:141:1612-20Peyrin-Biroulet L. Gastroenterology 2011:141:1621-8Peyrin-Biroulet L. Am J Gastroenterol 2012 doi: 10.1038/ajg.2012.181
NR
![Page 12: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/12.jpg)
Clinical Questions• Is skin cancer risk increased by therapy?
– Thiopurines – yes– Methotrexate – don’t know, probably not– Biologics – no NMSC, maybe melanoma
• If so, does the risk of continuing therapy outweigh the benefits?– In this case – consider stopping thiopurine
Uncertain if risk will decline– Annual skin exam and regular use of sunscreen and hats
![Page 13: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/13.jpg)
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
13
NMSC – Basal Cell Squamous Cell Melanoma
Thiopurine
antiTNF
![Page 14: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/14.jpg)
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
14
NMSC – Basal Cell Squamous Cell Melanoma
Thiopurine Continue or start:Active or Past, as long as Dermatology monitoringMTX prob ok
Stop:Only if significant recurrence or potential for disfiguring sequelae
antiTNF
![Page 15: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/15.jpg)
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
15
NMSC – Basal Cell Squamous Cell Melanoma
Thiopurine
antiTNF Continue or start:Active or Past, as long as Dermatology monitoring
Stop:NO, rarely necessary to stop
![Page 16: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/16.jpg)
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
16
NMSC – Basal Cell Squamous Cell
Melanoma
Thiopurine Start:-eradicated/resected/no mets-melanoma free for > 1 yrStop/Restart: -Hold for new onset?-Maybe ok to continue -Restart if melanoma free-Stop for metastatic ds
antiTNF
![Page 17: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/17.jpg)
Skin: Stop or Continue? What I do-Consult with Dermatology and then.….
17
NMSC – Basal Cell Squamous Cell
Melanoma
Thiopurine
antiTNF Start:-eradicated/resected/no mets-melanoma free for > 1 yrStop: -New Onset-?Restart if melanoma free > 1 yr-Do not restart <1yr or mets
![Page 18: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/18.jpg)
Lymphoma
18
![Page 19: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/19.jpg)
Questions Does immunosuppressant therapy
increase the risk of lymphoma? Do the benefits outweigh the risks? What do you do when a lymphoma
develops in the setting of IBD meds?
![Page 20: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/20.jpg)
AZA/6-MP are probably related to Lymphoma (Meta-analysis): SIR 4.06
AuthorAuthor ObservedObserved ExpectedExpectedConnellConnell 00 0.520.52
KinlenKinlen 22 0.240.24
FarrellFarrell 22 0.050.05
LewisLewis 11 0.640.64
FraserFraser 33 0.650.65
KorelitzKorelitz 33 0.610.61
TotalTotal 1111 2.712.71
SIR = 4.06, 95% CI 2.01 – 7.28Kandiel A et al. Gut. 2005:54:1121-25
![Page 21: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/21.jpg)
CESAME – 6MP/AZA OnlyLymphoma: HR 5.3
At cohort entry
N # Lymphomas
HR (95% CI)
Never exposed to thiopurines
10,810 6 Reference
On therapy with thiopurines
5,867 16 5.3 (2.0 – 13.9)
Previously discontinued thiopurines
2,809 2 1.0 (0.2 – 5.1)
Beaugerie L. Lancet 2009 DOI:10.1016/S0140-6736(09)61302-7
![Page 22: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/22.jpg)
• 8905 patients representing 20,602 pt-years of exposure• 13 Non-Hodgkin’s lymphomas • Mean age 52, 62% male• 10/13 exposed to IM* (really a study of combo Rx)
Risk of NH Lymphoma with anti-TNF + IM treatment for Crohn’s Disease: A Meta-Analysis
NHL rate per 10,000 SIR 95% CI
SEER all ages 1.9 - -
IM alone 3.6 - -
Anti-TNF + IM vs SEER 6.1 3.23 1.5-6.9
Anti-TNF+ IM vs IM alone 6.1 1.7 0.5-7.1
Siegel et al, CGH 2009;7:874. *not reported in 2
6.1 per 10,000 pt-years
![Page 23: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/23.jpg)
CESAME – Combo 6MP/AZA and antiTNF: SIR = 10.2
Therapy Patients # Lymph SIR 95% CINever thiopurine or TNF
22,706 6 1.5 0.5 – 3.2
Current thiopurine without TNF
14,729 13 6.5 3.5 – 11.2
Current thiopurine + TNF
1,929 2 10.2 1.2 – 36.9
Beaugerie L. Lancet 2009 DOI:10.1016/S0140-6736(09)61302-7
![Page 24: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/24.jpg)
Clinical Questions
• Does immunosuppressant therapy increase the risk of lymphoma?– Thiopurines – yes, but risk may revert after
discontinuation– antiTNFs – Probably not– Combination – Yes and probably more than
monotherapy
![Page 25: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/25.jpg)
Risk:Benefit Ratio
25
![Page 26: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/26.jpg)
Hepatosplenic T Cell Lymphoma
• 41 cases from FDA AERS among patients with IBD1
– Thiopurine alone 17– Anti-TNF alone 1– Combination therapy 23
• Characteristics2
– Median age 22.5 (12 – 58)– 93% male– Median time since initiation of thiopurines ~6 years
1. Deepak P. Am J Gastroenterol 2013; 108:99–1052. Kotlyar D. Clin Gastroenterol Hepatol 2011;9:36–41
![Page 27: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/27.jpg)
Lymphoma - Number Needed to Harm
Males Only 15-19 y.o. M(per 105)
20-24 y.o. M (per 105)
Lymphoma other than HSTCLAnnual incidence NHL + HD USA 5.2 7.0
Annual incidence NHL + HD with thiopurines (x4‡) 20.8 28.0
Annual mortality from lymphoma without thiopurines* 1.3 1.75
Annual mortality from lymphoma with thiopurines* 5.2 7.0
Excess deaths from thiopurine induced lymphoma 3.9 5.25
NNT to cause one death / year 25,641 19,074
‡ Kandiel A et al. Gut. 2005:54:1121-25* 5 year survival = 68% for NHL, 85% for HD, estimated at 75% for this example
‡ Kandiel A et al. Gut. 2005:54:1121-25* 5 year survival = 68% for NHL, 85% for HD, estimated at 75% for this example
![Page 28: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/28.jpg)
What to do if lymphoma develops while taking IMM/antiTNF?
28
![Page 29: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/29.jpg)
Case – Stop or Continue?
• 39 yo male CD in remission on 6MP/IFX for 8 yrs.
• Now with weight loss, sweats, and low grade fevers
29
![Page 30: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/30.jpg)
Crohn’s ds case: NHL while taking 6MP/IFX.
30
![Page 31: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/31.jpg)
After consulting with the oncologist….
…we stopped the 6MP/antiTNF, but after 3 months of chemorx, the
antiTNF was resumed. We did not restart the 6MP.
31
![Page 32: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/32.jpg)
On CT: Hepatosplenic T cell lymphoma – enlarged spleen, otherwise nonspecific.
Thiopurine must be stopped!
32
![Page 33: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/33.jpg)
Solid Tumors
33
![Page 34: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/34.jpg)
Case Continue or Stop?• 58 yo female with severe UC who has
been on IFX/6MP (50mg/d) for past 1yr• Just diagnosed with intraductal breast CA
(T1N0MX)• Strong FHx breast CA, pt opts for bilateral
mastectomy • After consultation with oncology, the
decision is to cont meds
34
![Page 35: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/35.jpg)
No clear association between thiopurines/antiTNFs and solid tumors
in IBD
Study Types of cancer
Number of patients
Statistically significant
Armstrong 2010 lung, breast 1955 NO
Fraser 2002 breast, bronchial, renal 6262 NO
Connell 1994 gastric, lung, breast, cervical 755 NO
![Page 36: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/36.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
36
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
Thiopurine
antiTNF
![Page 37: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/37.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
37
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
Thiopurine Young Males
Extremely rare (<.0001%)
Usually in combo with anti-TNFs
Not with MTX/antiTNF
Fatal
antiTNF
![Page 38: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/38.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
38
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
Thiopurine Young males
Hemophagocytic lymphohistiocytosis Very rare (<.001%)
Should we check EBV prior to starting in our young males?
antiTNF
![Page 39: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/39.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
39
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
Thiopurine Older pts, long duration of 6MP
Rare (<.01%)
Males > Females
antiTNF
![Page 40: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/40.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
40
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
ThiopurineStop
Never Restart
antiTNF
![Page 41: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/41.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
41
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
ThiopurineStop, lymphoma may regress
Never Restart
antiTNF
![Page 42: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/42.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
42
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
ThiopurineStop, lymphoma may resolve
Never Restart
antiTNF
![Page 43: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/43.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
43
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
Thiopurine
antiTNFStop, probably never restart
![Page 44: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/44.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
44
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
Thiopurine
antiTNFStop, but restart once lymphoma resolves
![Page 45: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/45.jpg)
Lymphoma: Stop or Continue? 3 types, Consult with Oncology and then.….
45
Hepatosplenic TCNo relation to EBV
After acute EBVInitially EBV -
PTLD-likeInitially EBV +
Thiopurine
antiTNFContinue, only stop if progression of lymphoma
![Page 46: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/46.jpg)
Solid Tumor: Stop or Continue? Consult with Oncology and then.….
46
Solid Tumors, e.g. Breast, Lung, Renal Probably no relationship to IBD meds
Thiopurine -Continue if curative resection, no need to stop
antiTNF -Continue if curative resection, no need to stop
![Page 47: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/47.jpg)
Solid Tumor: Stop or Continue? Consult with Oncology and then.….
47
Solid Tumors, e.g. Breast, Lung, Renal Probably no relationship to IBD meds
Thiopurine-Stop if metastatic ds and/or chemotherapy
antiTNF-Stop if metastatic ds and/or chemotherapy
![Page 48: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/48.jpg)
Solid Tumor: Stop or Continue? Consult with Oncology and then.….
48
Solid Tumors, e.g. Breast, Lung, Renal Probably no relationship to IBD meds
Thiopurine-Restart once chemo done and no active cancer (? > 1 yr)
antiTNF-Restart once chemo done and no active cancer (? > 1 yr)
![Page 49: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/49.jpg)
Should we continue or stop IBD meds if a cancer develops?
Depends on IBD
49
![Page 50: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/50.jpg)
Deep Remission
If in deep remission, maybe stopping IBD meds is ok and not
restarting them
50
![Page 51: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/51.jpg)
Not in deep remission or disabling IBDSkin Cancer
• Basal or Squamous Cell• Resected/Controlled
– CONTINUE all meds• Not controlled and/or disfiguring
– STOP azathioprine/6MP– CONTINUE anti-TNFs
• Melanoma• Resected/Eradicated > 1 year
– CONTINUE all meds• Multiple Skin Sites/Rapid Recurrence/Mets
– STOP anti-TNFs– CONTINUE – 6MP/AZA/MTX?
51
![Page 52: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/52.jpg)
Not in deep remission or disabling IBDLymphoma
• Acute EBV and lymphoma: • STOP AZA/6MP• CONTINUE anti-TNF, after lymphoma resolved (may not
even need to stop?)• Hepatosplenic T Cell lymphoma:
• STOP AZA/6MP and anti-TNF• PTLD-like lymphoma (likely EBV):
• STOP AZA/6MP• CONTINUE anti-TNF, after lymphoma resolved (may not
even need to stop?)
52
![Page 53: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/53.jpg)
Not in deep remission or disabling IBDSolid Tumors
6MP/AZA:- CONTINUE 6MP/AZA/MTX - Stop during chemoAnti-TNFs- CONTINUE if tumor resected/eradicated- STOP if metastatic ds or chemorx- RESTART once cancer eradicated/chemorx
stopped
53
![Page 54: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/54.jpg)
When you vote on who will win this debate
make sure you consider both halves of the debate, but also the
2 sides of TOM ULLMAN
54
![Page 55: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/55.jpg)
55
![Page 56: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/56.jpg)
Which half will you see today?…..
….the honest, kind, thoughtful, Tom Ullman?
56
![Page 57: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/57.jpg)
57
![Page 58: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/58.jpg)
Or ??????
…maybe that dazed look wasn’t because Tom just ran a race,
but…..
58
![Page 59: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/59.jpg)
59
![Page 60: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/60.jpg)
60
Playboy Ullman starring in American Hustle
![Page 61: Do I really have a chance of winning a debate when my side is to continue meds when CA develops?](https://reader036.vdocuments.mx/reader036/viewer/2022062410/56815a03550346895dc750ef/html5/thumbnails/61.jpg)
61